Regulation of the initiation of coronavirus JHM infection in primary oligodendrocytes and L-2 fibroblasts

Virology

Volumn 225, Issue 1, 1996, Pages 33-43

  Kalicharran, Kishna ^a   Mohandas, Devaki ^b   Wilson, Greame ^c   Dales, Samuel ^d,e  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Jeneil Biotech Inc   (United States)

^c Allelix Biopharmaceutical Inc   (Canada)

^d ROCKEFELLER UNIVERSITY   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CORONAVIRUS; DEPHOSPHORYLATION; FIBROBLAST; GENE EXPRESSION REGULATION; MATURATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALIA; CORONAVIRUS;

EID: 0030297277     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0572     Document Type: Article

References (49)

1. Asanaka, M., and Lai, M. M. C. (1993). Cell fusion studies identified multiple cellular factors involved in mouse hepatitis virus entry. Virology 197, 732-741.
2. Banner, L. R., Keck, J. G., and Lai, M. M. C. (1990). A clustering of RNA recombination sites adjacent to a hypervariable region of the peplomer gene of murine coronavirus. Virology 175, 548-555.
3. Baric, R. S., Nelson, G. W., Fleming, J. O., Deans, R. J., Keck, J. G., Casteel, N., and Stohlman, S. A. (1988). Interactions between Coronavirus nucleocapsid protein and viral RNAs: Implication for viral transcription. J. Virol. 62, 4280-4287.
4. Baru, M., and Manor, H. (1988). Induction of polyomavirus DNA replication by cyclic AMP and a tumor promoter. Intervirology 29, 328-333.
5. Beavo, J. A., Bechtel, P. J., and Krebs, E. G. (1974). Activation of protein kinase by physiological concentrations of cyclic AMP. Proc. Natl. Acad. Sci. USA 71, 3580-3583.
6. Beushausen, S., and Dales, S. (1985). In vivo and in vitro models of demyelinating disease XI. Tropism and differentiation regulate the infectious process of coronaviruses in primary explants of the rat CNS. Virology 141, 89-101.
7. Beushausen, S., Narindrasorasak, S., Sanwal, B. D., and Dales, S. (1987). In vivo and in vitro models of demyelinating disease: activation of the adenylate cyclase system influences JHM virus expression in explanted rat oligodendrocytes. J. Virol. 61, 3795-3803.
8. Budzilowicz, C. J., Wilczynski, S. P., and Weiss, S. R. (1985). Three intergenic regions of coronavirus mouse hepatitis virus strains A59 genome RNA contain a common nucleotide sequence that is homologous to the 3′ end of the viral mRNA leader sequence. J. Virol. 53, 834-840.
9. Cheley, S., and Anderson, R. (1981). Cellular synthesis and modification of murine hepatitis virus polypeptides. J. Gen. Virol. 54, 301-311.
10. Cohen, P. (1989). The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 58, 453-508.
11. Corbin, J. D., Keely, S. L., and Park, C. R. (1975). The distribution and dissociation of cyclic adenosine 3′:5′monophosphate-dependent protein kinases in adipose, cardiac and other tissues. J. Biol. Chem. 250, 218-225.
12. Correll, L. A., Woodford, T. A., Corbin, J. D., Mellon, P. L., and McKnight, G. S. (1989). Functional characterization of cAMP-binding mutations of type 1 protein kinase. J. Biol. Chem. 264, 16672-16678.
13. Coulter-Mackie, M., Adler, R., Wilson, G., and Dales, S. (1985). In vivo and in vitro models of demyelinating disease. XII. Persistence and expression of corona JHM virus functions in RN2-2 Schwannoma cells during latency. Virus Res. 3, 245-262.
14. Feinberg, A. P., and Vogelstein, B. (1983). A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6-13.
15. David-Ferreira, J. F., and Manaker, R. A. (1965). An electron microscope study of the development of a mouse hepatitis virus in tissue culture cells. J. Cell. Biol. 24, 57-65.
16. Flintoff, W. F., and Van Dinter, S. (1989). Several rat cell lines share a common defect in their inability to internalize murine coronaviruses efficiently. J. Gen. Virol. 70, 1713-1724.
17. Flockhart, D. A., and Corbin, J. D. (1982). Regulatory mechanisms in the control of protein kinases. Crit. Rev. Biochem. 12, 133-186.
18. Gallagher, T. M., Escaramis, and Buchmeier, M. J. (1991). Alteration of the pH dependence of coronavirus-induced cell fusion: Effect of mutations in the spike glycoprotein. J. Virol. 65, 1916-1928.
19. Hidaka, H., Inagaki, M., Kawamoto, S., and Sasaki, Y. (1984). Isoquinoline sulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23, 5036-5041.
20. Ingebritsen, J. S., and Cohen, P. (1983). Protein phosphatases: Properties and role in cellular regulation. Science 221, 331-338.
21. Ishihara, H., Martin, B. L., Brautigan, D. L., Karaki, H., Ozaki, H., Kato, Y., Fusetani, N., Watabe, S., Hashimoto, K., Uemura, D., and Hartshorne, D. J. (1989). Calyculin and okadaic acid: inhibitors of protein phosphatase activity. Biochem. Biophys. Res. Commun. 159, 871-877.
22. Jurgensen, S. R., Chock, P. B., Taylor, S., Vandenheede, J. R., and Merlevede, W. (1985). Inhibition of the Mg(II)-ATPdependent phosphoprotein phosphatase by the regulatory subunit of cAMP dependent protein kinase. Proc. Natl. Acad. Sci. USA 82, 7565-7569.
23. Khatra, B. S., Printz, R., Cobb, C. E., and Corbin, J. D. (1985). Regulatory subunit of cAMP-dependent protein kinase inhibits phosphoprotein phosphatase. Biochem. Biophys. Res. Commun. 130, 567-573.
24. Kooi, C., Mizzen, L., Alderson, C., Daya, M., and Anderson, R. (1988). Early events of importance in determining host cell permissiveness to mouse hepatitis virus infection. J. Gen. Virol. 69, 1125-1135.
25. Krzystyniak, K., and Dupuy, J. M. (1984). Entry of mouse hepatitis virus 3 into cells. J. Gen. Virol. 65, 227-231.
26. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
27. Lucas, A., Flintoff, W., Anderson, R., Percy, D., Coulter-Mackie, M., and Dales, S. (1977). In vivo and In vitro models of demyelinating diseases: tropism of the JHMV strain of murine hepatitis virus for cells of glial origin. Cell 12, 553-560.
28. Mallucci, L. (1966). Effect of chloroquine on lysosomes and on growth of mouse hepatitis virus (MHV-3). Virology 28, 355-362.
29. Maniatis, T., Fritsch, E. F., and Sambrook, J. (1982). In "Molecular Cloning: A Laboratory Manual," pp. 466-467. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
30. Mellon, P., Clegg, C. H., Correll, L. A., and McKnight, G. S. (1989). Regulation of transcription by cyclic AMPdependent protein kinase. Proc. Natl. Acad. Sci. USA 86, 4887-4891.
31. Miller, C. A., and Carrigan, D. R. (1982). Reversible repression and activation of measles virus infection in neural cells. Proc. Natl. Acad. Sci. USA 79, 1629-1633.
32. Mizzen, L., Hilton, A., Cheley, S., and Anderson, R. (1985). Attenuation of murine coronavirus infection by ammonium chloride. Virology 142, 378-388.
33. Mohandas, D. V., and Dales, S. (1991). Endosomal association of a protein phosphatase with high dephosphorylating activity against a coronavirus nucleocapsid protein. FEBS Lett. 282, 419-424.
34. Pasick, J. M. M., and Dales, S. (1991). Infection by Coronavirus JHM of rat neurons and oligodendrocyte-type-2 astrocyte lineage cells during distinct developmental stages. J. Virol. 65, 5013-5028.
35. Robbins, S. G., Frana, M. F., McGowan, J. J., Boyle, J. F., and Holmes, K. V. (1986). RNA-binding proteins of coronavirus MHV: detection of monomeric and multimeric N protein and RNA overlay protein blot assay. Virology 150, 402-410.
36. Robbins, S. J., and Rapp, F. (1980). Inhibition of measles virus replication by cyclic AMP. Virology 106, 317-326.
37. Rubin, C., and Rosen, O. (1975). Protein phosphorylation. Annu. Rev. Biochem. 44, 831-887.
38. Scott, J. D. (1991). Cyclic nucleotide-dependent protein kinase. Pharm. Ther. 50, 123-145.
39. Shenolikar, S. (1994). Protein serine/threonine phosphatases: new avenues for cell regulation. Annu. Rev. Cell Biol. 10, 55-86.
40. Simon, M-N., Driscoll, D., Mutzel, R., Paitr, D., Williams, J., and Veron, M. (1989). Overproduction of the regulatory subunit of the cAMP-dependent protein kinase blocks the differentiation of Dictostelium discoideum. EMBO J. 8, 2039-2043.
41. Sorensen, O., Percey, A., and Dales, S. (1980). In vivo and In vitro models of demyelinating disease III. JHM virus infection of rats. Arch. Neurol. 37, 478-484.
42. Srivastava, A. K., Khandelwal, R. C., Chiasson, J. C., and Haman, A. (1988). Inhibitory effect of the regulatory subunit of type 1 cAMP-dependent protein kinase on phosphoprotein phosphatase. Biochem. Int. 16, 303-310.
43. Stohlman, S. A., Fleming, J. O., Patton, C. D., and Lai, M. M. C. (1983). Synthesis and subcellular localization of the murine coronavirus nucleocapsid protein. Virology 130, 527-532.
44. Towbin, H., Staehelin, T., and Gordon, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4355.
45. Van Alstyne, D., and Paty, D. W. (1983). The effect of dibutyryl cyclic AMP on restricted replication of rubella virus in rat glial cells in culture. Virology 124, 173-180.
46. Van Dinter, S., and Flintoff, W. F. (1987). Rat glial C6 cells are defective in murine coronavirus internalization. J. Gen. Virol. 68, 1677-1685.
47. Wilbur, S. M., Nelson, G. W., Lai, M. M. C., McMillan, M., and Stohlman, S. A. (1986). Phosphorylation of the mouse hepatitis virus nucleocapsid protein. Biochem. Biophys. Res. Commun. 141, 7-12.
48. Wilson, G. A. R., Beushausen, S., and Dales, S. (1986). In vivo and In vitro models of demyelinating diseases. XV. Differentiation influences the regulation of coronavirus infection in primary explants of mouse CNS. Virology 151, 253-264.
49. Yokomori, K., Asanaka, M., Stohlman, S. A., and Lai, M. M. C. (1993). A spike protein dependent cellular factor other than the virus receptor is required for mouse hepatitis virus entry. Virology 196, 45-56.